HMGB-1 Levels in Painful Knee Arthroplasty: Is it Possible to Distingue Periprosthetic Joint Infection and Aseptic Loosening?

Aseptic loosening HMGB-1 Periprosthetic joint infections Three phase bone scintigraphy Total knee arthroplasty

Journal

Indian journal of orthopaedics
ISSN: 0019-5413
Titre abrégé: Indian J Orthop
Pays: Switzerland
ID NLM: 0137736

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 08 01 2023
accepted: 27 04 2023
pmc-release: 11 05 2024
medline: 29 6 2023
pubmed: 29 6 2023
entrez: 29 6 2023
Statut: epublish

Résumé

We investigated the efficiency of high mobility group box-1 protein (HMGB-1) in differentiation of asymptomatic knee prosthesis, and periprosthetic joint infection and aseptic loosening causing painful knee prosthesis. The data of patients who consulted our clinic for checking after total knee arthroplasty surgery were recorded prospectively. Blood levels of CRP, ESR, WBC, and HMGB-1 were recorded. Patients whose examination and routine tests were within normal limits comprised group I, asymptomatic total knee arthroplasty (ATKA). Painful patients with abnormal test results underwent three phase bone scintigraphy for further investigation Patients with periprosthetic joint infection (PJI) and aseptic loosening (AL) according to scintigraphy comprised group II and group III, respectively. The mean values of HMGB-1 and cut-off values according to the groups and their correlations with other inflammatory parameters were determined. Seventy-three patients were included in the study. Significant differences were observed in three groups, in terms of CRP, ESR, WBC, and HMGB-1. The cut-off value of HMGB-1 was determined as 15.16 ng/ml between ATKA and PJI, 16.92 ng/ml between ATKA and AL, and 27.87 ng/ml between PJI and AL, respectively. Accordingly, the sensitivity, and specificity of HMGB-1 in differentiation of ATKA and PJI were 91%, 88%, and in differentiation of ATKA and AL were 91%, 96%, and in differentiation of PJI and AL were 81%, 73%, respectively. HMGB-1 may be utilized as an additional blood test in the differential diagnosis of problematic knee prosthesis patients.

Identifiants

pubmed: 37384002
doi: 10.1007/s43465-023-00903-9
pii: 903
pmc: PMC10293519
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1023-1031

Informations de copyright

© Indian Orthopaedics Association 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Déclaration de conflit d'intérêts

Conflict of interestThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Technol Health Care. 2014;22(5):767-73
pubmed: 25134961
Cancer Biomark. 2016 Apr 1;17(1):17-20
pubmed: 27062570
Bone Joint J. 2014 Nov;96-B(11 Supple A):101-4
pubmed: 25381419
Int Orthop. 2020 Jan;44(1):3-14
pubmed: 31641803
Chirurg. 2016 Oct;87(10):813-21
pubmed: 27439064
J Nucl Med. 2004 Nov;45(11):1864-71
pubmed: 15534056
Clin Orthop Relat Res. 2016 Jul;474(7):1630-9
pubmed: 26821163
J Arthroplasty. 2019 Jan;34(1):126-131
pubmed: 30293756
Injury. 2010 Dec;41(12):1323-7
pubmed: 20887988
J Bone Miner Res. 2008 Jul;23(7):1084-96
pubmed: 18302500
Acta Biomed. 2017 Jun 07;88(2S):68-77
pubmed: 28657567
Knee Surg Relat Res. 2022 Jun 18;34(1):29
pubmed: 35717341
J Nucl Med. 1987 Oct;28(10):1546-9
pubmed: 3655908
J Arthroplasty. 2014 Sep;29(9):1774-8
pubmed: 25007726
Cytokine. 2003 Dec 21;24(6):254-65
pubmed: 14609567
J Orthop Surg Res. 2022 Jan 22;17(1):42
pubmed: 35065660
J Arthroplasty. 2014 Apr;29(4):843-9
pubmed: 24290740
J Bone Joint Surg Am. 2012 Jul 18;94(14):e104
pubmed: 22810411
J Arthroplasty. 2019 Feb;34(2S):S339-S350
pubmed: 30348566
Bone Joint J. 2015 Oct;97-B(10 Suppl A):20-9
pubmed: 26430083
J Knee Surg. 2019 Oct;32(10):941-946
pubmed: 30336501
J Bone Joint Surg Am. 2011 Jul 20;93(14):1355-7
pubmed: 21792503
Interdiscip Perspect Infect Dis. 2013;2013:542796
pubmed: 24023542
Clin Orthop Relat Res. 2013 Jul;471(7):2374-82
pubmed: 23440616
Pharmacol Res. 2016 Sep;111:534-544
pubmed: 27378565
Clin Orthop Relat Res. 2017 Jul;475(7):1874-1886
pubmed: 28299718
Acta Orthop. 2007 Oct;78(5):629-39
pubmed: 17966022
Crit Care Med. 2005 Mar;33(3):564-73
pubmed: 15753748
Semin Nucl Med. 2017 Nov;47(6):630-638
pubmed: 28969761
Clin Orthop Relat Res. 1990 Feb;(251):183-8
pubmed: 2295172
J Arthroplasty. 2011 Sep;26(6 Suppl):99-103.e1
pubmed: 21570803
Nature. 2002 Jul 11;418(6894):191-5
pubmed: 12110890
J Bone Joint Surg Am. 2013 Apr 3;95(7):644-51
pubmed: 23553300
Radiology. 2004 May;231(2):333-41
pubmed: 15044748
J Bone Joint Surg Am. 2015 May 6;97(9):715-20
pubmed: 25948517
Clin Chim Acta. 2007 Jan;375(1-2):36-42
pubmed: 16979611
BMC Musculoskelet Disord. 2018 Feb 14;19(1):55
pubmed: 29444666

Auteurs

İbrahim Halil Rızvanoglu (İH)

Department of Orthopedics and Traumatology, NCR International Hospital, Mücahitler Neighborhood, No: 56. Şehitkamil, 27090 Gaziantep, Turkey.

Bülent Sakarya (B)

Department of Orthopedics and Traumatology, Mersin Toros Government Hospital, Cemalpaşa Neighborhood. 5314 Street, Akdeniz, Mersin, Turkey.

Necla Benlier (N)

Department of Medical Pharmacology, Sanko University School of Medicine, Ali Fuat Cebesoy Boulevard. No: 45, Şehitkamil, Gaziantep, Turkey.

Füsun Kökçü (F)

Department of Nuclear Medicine, Medical Park Gaziantep Hospital, Mücahitler Neighborhood, 52063 St., Şehitkamil, 27584 Gaziantep, Turkey.

Classifications MeSH